• Measles Vaccine

    The Centers for Disease Control and Prevention (CDC) monitors measles cases and outbreaks in the United States. While vaccination rates overall remain strong, there can be pockets of low community vaccination coverage due to vaccine hesitancy and vaccine misinformation. As a result of decreased vaccination coverage, communities can become vulnerable to measles outbreaks.

    A recent WHO report indicates that measles vaccination coverage has steadily declined since the beginning of the COVID-19 pandemic, creating a greater risk for outbreaks. 

    CDC encourages clinicians to encourage all their patients, including children, teens, and adults, to be up-to-date on MMR vaccinations and other recommended vaccines. CDC recommends that children receive two doses of measles-mumps-rubella (MMR) vaccine, with the first dose between 12 and 15 months of age and the second dose between 4 and 6 years of age.  

    Health care professionals should also be vigilant about identifying and reporting suspected measles cases. This quick-diagnosis guide from the CDC can help. 

    Talk to Your Patients About Vaccination

    Be prepared to talk with your patients and reassure them that the benefits of measles immunization outweigh any adverse effects associated with the measles-mumps-rubella (MMR) vaccine.

    The routine recommendation for the MMR vaccine starts at age 12 months. However, infants can get the vaccine as early as 6 months old if they are traveling outside of the United States. Many people may not be aware of the vaccination schedules recommended when traveling abroad, so it is helpful to ask parents with small children if they may be traveling.

    Important talking points to share when discussing the MMR Vaccine with patients:

    • Approximately 9 of 10 susceptible persons with close contact with a measles patient will develop measles.
    • Approximately 30% of patients who have measles develop one or more complications.
    • More than 93% of individuals who receive a single dose of MMR will develop immunity to measles. Two doses increase this protection to approximately 97%.

    Some parents may consider refusing or delaying vaccinations because they are concerned about the number of vaccines given in a child’s first two years of life. Encourage your patients to follow the recommended immunization schedules, which are based on the best available data and designed to maximize benefit and minimize risk.

    Each year, the American Academy of Family Physicians (AAFP) and the Advisory Committee on Immunization Practices (ACIP) collaborate to develop recommendations for the routine use of vaccines in children, adolescents, and adults

    Additional measles resources to share with patients are available on FamilyDoctor.org.

    MMR Vaccine Safety

    Parents may be concerned about fever, seizure, and autism as reasons for refusing the MMR vaccine. Reassure your patients that getting the MMR vaccine is much safer than getting measles. Although some people may experience mild temporary adverse effects such as burning or stinging at the site of the shot, fever, or rash, it is important to emphasize that most people who get the vaccine have no problems with it. Severe adverse effects of the MMR vaccine — such as immunization-related seizures — are rare.

    If parents are concerned about an association between MMR vaccination and autism, reassure them that the claim that the MMR vaccine causes autism is a myth and is not true. The single study that purported to show a connection between the MMR vaccine and autism has been discredited and retracted. Numerous well conducted medical studies have consistently repeatedly shown that there is not an increased risk of autism after receiving the MMR vaccine. 

    Why the MMR Vaccine Is Important

    • Measles is highly contagious and spreads quickly. Approximately 9 of 10 of susceptible individuals who are exposed to the measles virus will develop the disease.
    • Most cases of measles in the United States are brought back and spread throughout communities by unvaccinated travelers returning from countries where measles is more common.
    • Approximately 30% of patients who have measles develop one or more complications. Common complications from measles include diarrhea, otitis media, and pneumonia, which is the most common cause of associated death.
    • Complications are more common among children younger than age 5 years and adults older than age 20 years.
    • Most cases of measles occur in individuals who have not received the MMR vaccine.
    • More than 95% of individuals who receive a single dose of MMR will develop immunity to all three viruses (measles, mumps, and rubella). A second dose provides immunity to almost all individuals who did not respond to the first dose.
    • Administering the MMR vaccine helps protect members of the community who are not eligible for the vaccine — such as infants or immunocompromised individuals, because the spread of contagious disease is contained.

    Acknowledgement: This resource is supported by an unrestricted grant from Johnson & Johnson Services, Inc.